EI DuPont de Nemours & Co.
(DD:NYSE)
Snapshot of EI DuPont de Nemours & Co. (DD)
|
OPEN
$34.79
|
PREVIOUS CLOSE
$34.51
|
|
|
DAY HIGH
$35.27
|
DAY LOW
$34.60
|
|
|
52 WEEK HIGH
11/18/09 - $35.35
|
52 WEEK LOW
03/9/09 - $16.05
|
|
|
MARKET CAP
31.4B
|
AVERAGE VOLUME 3 mo
6.3M
|
|
|
DILUTED EPS TTM
$0.74
|
SHARES OUTSTANDING
903.7M
|
|
|
EX-DATE
11/10/09
|
P/E TTM
47.0x
|
|
|
DIVIDEND
$1.64
|
DIVIDEND YIELD
4.72%
|
|
| K = Thousands M = Millions B = Billions | ||
related business week news
Studies show that hiring the disabled does not lead to higher accommodation costs, worker comp, or sick leave, yet these myths persist
Reigniting basic research can repair the broken U.S. business model and put Americans back to work
DARPA, the Defense Dept. agency that helped invent the Internet, is setting its sights on cleantech
DARPA, the Defense Dept. agency that helped invent the Internet, is setting its sights on alternative energy
related news
DD Details
E. I. du Pont de Nemours and Company (DuPont) operates as a science and technology company in various disciplines, including agriculture, industrial biotechnology, chemistry, biology, materials science, and manufacturing. It operates in five segments: Agriculture & Nutrition, Coatings & Color Technologies, Electronic & Communication Technologies, Performance Materials, and Safety & Protection. The Agriculture & Nutrition segment offers benzene and carbamic acid related intermediates, copper, insect control products, natural gas, soybeans, soy flake, soy lecithin, sulfonamides, corn, and soybean seeds. The Coatings & Color Technologies segment provides automotive finishes, industrial coatings, and titanium dioxide white pigments. The Electronic & Communication Technologies segment offers a range of materials for the electronics industry, flexographic printing and color communication systems, and various fluoropolymer and fluorochemical products. The Performance Materials segment provides thermoplastic, and thermoset engineering polymers and elastomers to fabricate components for mechanical and electrical systems, as well as specialized resins and films used in packaging and industrial applications, sealants and adhesives, sporting goods, and interlayers for laminated safety glass. The Safety & Protection segment offers specialty and industrial chemicals, nonwovens, aramids, and solid surfaces. The company also has interest in two antihypertensive drugs, the Cozaar and Hyzaar. It serves construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security and safety consulting, refrigeration, insulation, aerosol propellants, aerospace, automotive, electronics, chemical processing, and house ware industries. The company operates in the United States, Europe, the Asia Pacific, Canada, and Latin America. DuPont was founded in 1802 and is headquartered in Wilmington, Delaware.
DD Top Compensated Officers
Key developments for EI DuPont de Nemours & Co. (DD)
EI DuPont de Nemours & Co. provided earnings guidance for the full year 2010. It expects to grow earnings in 2010 despite anticipated declines in pharmaceutical royalties after patents expire in 2010 to a range of $2.10 to $2.40 per share. The company reaffirmed earnings outlook for the full year 2009. It expects earnings per share of $1.95 to $2.05, excluding significant items which are estimated to be $0.15 per share for full-year 2009 or $1.80 to $1.90 per share on a reported basis.
EI DuPont de Nemours & Co. announced that its board of directors has elected Chief Executive Officer Ellen Kullman, 53, Chair effective Dec. 31. Charles O. Holliday, Jr., 61, Chair, will retire from the board after 11years as its chairman. As previously announced in September 2008, Kullman became CEO effective Jan. 1 after Holliday served as DuPont's CEO for 10 years. Holliday continued as Chair of DuPont and as a member of the board for a brief transition until Kullman's expected succession as Chair.
EI DuPont de Nemours & Co. and Makhteshim-Agan of North America Inc. announced that they have entered into a royalty-bearing license agreement for DuPont Crop Protection patents related to a novel homogeneous blend technology that enables the efficient combination of different pesticides. This agreement confirms the validity of certain DuPont patents granted in the United States and Canada and settles the litigation claims between MANA and DuPont regarding the U.S. patent.
Stock Quotes
| Recently Viewed | |||
| DD | $34.76 USD | +0.25 | |
|---|---|---|---|
| BBY | $43.71 USD | +0.41 | |
| ALA (DE) | €0.54 EUR | +0.015 | |
| SGI | $6.30 USD | +0.03 | |
| U (CA) | C$7.00 CAD | +0.14 | |
Market data is delayed at least 20 minutes.
DD Competitors
| Company | Last | Change |
| 3M Company | $77.73 USD | +1.09 |
| Honeywell International Inc | $38.68 USD | +0.64 |
| Ericsson B | kr70.50 SEK | +0.40 |
| Mitsubishi Chemical Holdings Corporation | ¥320.00 JPY | -1.00 |
| View Industry Companies | ||
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | DD | Industry Range |
| Price/Earnings | 46.4x |
|
| Price/Sales | 1.2x |
|
| Price/Book | 4.2x |
|
| Price/Cash Flow | 45.5x |
|
| TEV/Sales | 0.6x |
|
|
DD |
||
DD transactions
| Type Date |
Target |
|
Merger/Acquisition
June 28, 2009 |
EI DuPont de Nemours & Co., Linuron Herbicide Assets |
|
Bankruptcy
May 31, 2009 |
Caraustar Industries Inc. |
Companies Toolbox
SEARCH FOR JOBS
Post a Job- El Paso, IL-DuPont
- Arkansas-DuPont
- Ohio-DuPont
- Texas-E.I. DuPont De Nemours & Company
Jobs by SimplyHired
Recommend A Data Enhancement Or Correction
For EI DuPont de Nemours & Co. (DD) Snapshot
Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.
Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.
Please indicate which data is in error.
Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.
Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.



